[HTML][HTML] Better outcome of off-label high-dose ceftazidime in hemato-oncological patients with infections caused by extensively drug-resistant Pseudomonas …

A Zavrelova, P Paterova, P Zak, B Visek… - … of Hematology and …, 2023 - ncbi.nlm.nih.gov
Background P. aeruginosa sepsis in immunocompromised patients is a serious complication
of cancer treatment, especially in the case of an Extensively Drug Resistant (XDR) …

Going local: Evaluating guideline adherence and appropriateness of antibiotic prescribing in patients with febrile neutropenia at an academic teaching hospital

R Liu, MR Gitman, AM Morris, M So - Antimicrobial Stewardship & …, 2023 - cambridge.org
Background: Febrile neutropenia (FN) is a medical emergency with significant morbidity and
mortality for oncology patients, requiring comprehensive workup and timely antibiotic …

Carbapenem resistance in Enterobacterales bloodstream infections among children with cancer or post-haematopoietic stem cell transplant: a retrospective cohort …

JF López-Cubillos, A Díaz, VC Cárdenas… - Journal of …, 2023 - academic.oup.com
Background Risk factors for carbapenem resistance in Enterobacterales bloodstream
infections among children with cancer or post-HSCT have not been thoroughly explored …

Pseudomonas aeruginosa ExoU-associated virulence in HCT recipients and patients with hematologic malignancies

L Fontana, L Strasfeld, M Hakki - Blood Advances, 2023 - ashpublications.org
Pseudomonas aeruginosa remains a significant pathogen in patients undergoing
chemotherapy for hematologic malignancies (HMs) and hematopoietic cell transplant (HCT) …

Emergence of non-susceptibility during persistent Pseudomonas aeruginosa bacteraemia in haematopoietic cell transplant recipients and haematological …

L Fontana, M Hakki - JAC-Antimicrobial Resistance, 2021 - academic.oup.com
Background Systematic studies pertaining to the emergence of resistance during therapy of
Pseudomonas aeruginosa bloodstream infections (BSIs) in haematopoietic cell transplant …

Long-term impact of an educational antimicrobial stewardship program on management of patients with hematological diseases

AB Guisado-Gil, M Aguilar-Guisado, G Peñalva… - Antibiotics, 2021 - mdpi.com
Antimicrobial stewardship programs (ASPs) in hematological patients are especially
relevant. However, information about ASPs in this population is scarce. For 11 years, we …

Anitmicrobial Susceptibility to Microoranisms in Hematological Malignancies; A Need to Review Institutional Protocols

N Anwar, N Fatima, A Jamal, QUA Rizvi… - Journal of the Pediatric …, 2023 - academic.oup.com
Introduction Febrile neutropenia is a medical emergency in patients with hematological
malignancies. The severity of neutropenia and the duration of infection have an important …

[HTML][HTML] Current Microbiological Testing Approaches and Documented Infections at Febrile Neutropenia Onset in Patients with Hematological Malignancies

M Chumbita, O Peyrony, C Teijón-Lumbreras… - International Journal of …, 2024 - Elsevier
Introduction Identifying infection etiology in febrile neutropenia (FN) is vital. This study
explores different microbiological approaches and their impact on diagnosing infections in …

[HTML][HTML] In vitro activity of imipenem/releactam and comparator agents against clinical bacterial isolates from patients with cancer

KVI Rolston, BZ Gerges, R Reitzel… - Journal of Global …, 2022 - Elsevier
Objectives Gram-negative bacilli (GNB) are currently the predominant bacterial pathogens in
patients with cancer. Many GNB have become problematic due to the widespread …

[HTML][HTML] 不同中性粒细胞水平恶性血液病患者血流感染病原菌分布的特点分析

刘晨光, 廖爱军 - Chinese Journal of Hematology, 2023 - ncbi.nlm.nih.gov
血流感染是一种全身感染性疾病, 主要由各种病原微生物或其产生的毒素进入血液引起[1].
常见的临床表现包括发热, 寒战等症状, 严重的血流感染可导致感染性休克和弥散性血管内凝血 …